Not finding it? Sign in to also search OpenAlex live.
-
An Optimized Crovalimab Dose and Regimen Reduced the Formation of Drug-Target-Drug Complexes in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Phase I/II COMPOSER Trial
Jun‐ichi Nishimura, Antoine Soubret, Simon Buatois, Jean‐Eric Charoin, Sasha Sreckovic, Christoph Marcus Bucher, +21 more
3citations -
COMPOSER Part 4: An Optimized Dosing Strategy for Crovalimab in the Treatment of Complement Inhibitor-Naïve or -Experienced Patients with Paroxysmal Nocturnal Hemoglobinuria
Régis Peffault de Latour, Simona Sica, Julia G. Ramos, Jules Hernández‐Sánchez, Jin Seok Kim, Anna Kiialainen, +11 more
3citations -
Exploring the role of an initiator in a population health management initiative: insights from action research2024 Journal of Integrated Care article Health Professions Health Policy Implementation Science Open access
Anna Francisca Teresia Maria van Ede, Marc Abraham Bruijnzeels, Mattijs Everard Numans, Katharina Viktoria Stein
2citations -
Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients2021 Liver Transplantation article Immunology and Microbiology T-cell and B-cell Immunology Open access
Aafke A. Duizendstra, Robert Jacobus de Knegt, Shanta Mancham, Mariska Klepper, Dave L. Roelen, Simone H. Brand‐Schaaf, +8 more
12citations -
Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single-center study2020 American Journal of Transplantation article Medicine Mesenchymal stem cell research Open access
Geertje J. Dreyer, Koen E. Groeneweg, Sebastiaan Heidt, Dave L. Roelen, Melissa van Pel, Helene Roelofs, +9 more
41citations
11 results